Alcon (ALC) Stock Forecast & Price Target

434 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ALC Analyst Ratings

Moderate Buy

7 Buy

2 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Alcon

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ALC Stock 12 Month Forecast

Average Price Target

$87.08

▲(19.82% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Alcon in the last 3 months. The average price target is $87.08 with a high forecast of $103.32 and a low forecast of $58.34. The average price target represents a 19.82% change from the last price of $72.67.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"57":"$57","104":"$104","68.75":"$68.8","80.5":"$80.5","92.25":"$92.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":103.318435,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$103.32</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":87.07585323288137,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$87.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":58.344528,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$58.34</span>\n  </div></div>","useHTML":true}}],"tickPositions":[57,68.75,80.5,92.25,104],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.75,74.17834115384615,76.60668230769231,79.03502346153846,81.46336461538462,83.89170576923077,86.32004692307692,88.74838807692308,91.17672923076923,93.60507038461537,96.03341153846154,98.46175269230768,100.89009384615383,{"y":103.318435,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.75,72.92891178714473,74.10782357428944,75.28673536143417,76.46564714857888,77.64455893572361,78.82347072286832,80.00238251001305,81.18129429715776,82.36020608430249,83.5391178714472,84.71802965859193,85.89694144573664,{"y":87.07585323288137,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,71.75,70.71880984615385,69.68761969230769,68.65642953846154,67.62523938461538,66.59404923076923,65.56285907692308,64.53166892307692,63.50047876923077,62.46928861538461,61.43809846153846,60.406908307692305,59.37571815384615,{"y":58.344528,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":79.426,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.748,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.534,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.823,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.43,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.998,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.272,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.146,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.733,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.7,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.82,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.94,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.75,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$103.32

Average Price Target$87.08

Lowest Price Target$58.34

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Larry Biegelsen

Wells Fargo

$86

Buy

18.34%

Upside

Reiterated

09/18/26

Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)

Sam England

Berenberg Bank

$103.32

Buy

42.17%

Upside

Reiterated

09/10/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and AbbVie (NYSE: ABBV)

Falko Friedrichs

Deutsche Bank

$85.09→$88.73

Buy

22.10%

Upside

Reiterated

08/17/26

Alcon price target raised to CHF 73 from CHF 70 at Deutsche BankAlcon price target raised to CHF 73 from CHF 70 at Deutsche Bank

Graham Doyle

UBS

$104.53→$100.89

Buy

38.83%

Upside

Reiterated

08/14/26

Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)

Anthony Petrone

Mizuho Securities

$85

Buy

16.97%

Upside

Reiterated

08/13/26

Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (NASDAQ: SPRB) and Alcon (NYSE: ALC)

Steven Lichtman

William Blair

―

Hold

―

Assigned

08/12/26

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)

David Adlington

J.P. Morgan

$78.4

Hold

7.88%

Upside

Reiterated

08/12/26

J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)

David Saxon

Needham

$95→$98

Buy

34.86%

Upside

Reiterated

08/11/26

Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers

Julien Ouaddour

Bank of America Securities

$60.78→$58.34

Sell

-19.71%

Downside

Reiterated

07/21/26

Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48

Jasper Hellweg

Argus Research

$85

Buy

16.97%

Upside

Reiterated

07/01/26

Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus

Brett Fishbin

KeyBanc

$88

Buy

21.10%

Upside

Reiterated

06/12/26

Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)

Veronika Dubajova

Citi

$112→$103

Buy

41.74%

Upside

Reiterated

06/11/26

Alcon (ALC) Gets a Buy from Citi

Thomas Stephan

Stifel Nicolaus

$70

Hold

-3.67%

Downside

Reiterated

05/21/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (NYSE: ALC) and Oruka Therapeutics (NASDAQ: ORKA)

Jeff Johnson

Robert W. Baird

$98→$90

Buy

23.85%

Upside

Reiterated

05/07/26

Alcon price target lowered to $90 from $98 at BairdAlcon price target lowered to $90 from $98 at Baird

Matt Miksic

Barclays

$78

Hold

7.33%

Upside

Reiterated

05/06/26

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Larry Biegelsen

Wells Fargo

$86

Buy

18.34%

Upside

Reiterated

09/18/26

Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)

Sam England

Berenberg Bank

$103.32

Buy

42.17%

Upside

Reiterated

09/10/26

Analysts Offer Insights on Healthcare Companies: Alcon (NYSE: ALC) and AbbVie (NYSE: ABBV)

Falko Friedrichs

Deutsche Bank

$85.09→$88.73

Buy

22.10%

Upside

Reiterated

08/17/26

Alcon price target raised to CHF 73 from CHF 70 at Deutsche BankAlcon price target raised to CHF 73 from CHF 70 at Deutsche Bank

Graham Doyle

UBS

$104.53→$100.89

Buy

38.83%

Upside

Reiterated

08/14/26

Analysts' Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)

Anthony Petrone

Mizuho Securities

$85

Buy

16.97%

Upside

Reiterated

08/13/26

Analysts Offer Insights on Healthcare Companies: Spruce Biosciences (NASDAQ: SPRB) and Alcon (NYSE: ALC)

Steven Lichtman

William Blair

―

Hold

―

Assigned

08/12/26

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Alcon (NYSE: ALC)

David Adlington

J.P. Morgan

$78.4

Hold

7.88%

Upside

Reiterated

08/12/26

J.P. Morgan Sticks to Their Hold Rating for Alcon (ALC)

David Saxon

Needham

$95→$98

Buy

34.86%

Upside

Reiterated

08/11/26

Analyst Reiterates Buy on Alcon After Q2 Beat, Raised Earnings Outlook, and Strengthening Multi-Pillar Growth Drivers

Julien Ouaddour

Bank of America Securities

$60.78→$58.34

Sell

-19.71%

Downside

Reiterated

07/21/26

Alcon Cut to Sell as Underperformance, Competitive Pressure and Softer Markets Drive Price Target Reduction from CHF50 to CHF48

Jasper Hellweg

Argus Research

$85

Buy

16.97%

Upside

Reiterated

07/01/26

Alcon price target lowered to $85 from $90 at ArgusAlcon price target lowered to $85 from $90 at Argus

Brett Fishbin

KeyBanc

$88

Buy

21.10%

Upside

Reiterated

06/12/26

Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (NYSE: EVMN), Immunome (NASDAQ: IMNM) and Alcon (NYSE: ALC)

Veronika Dubajova

Citi

$112→$103

Buy

41.74%

Upside

Reiterated

06/11/26

Alcon (ALC) Gets a Buy from Citi

Thomas Stephan

Stifel Nicolaus

$70

Hold

-3.67%

Downside

Reiterated

05/21/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (NYSE: ALC) and Oruka Therapeutics (NASDAQ: ORKA)

Jeff Johnson

Robert W. Baird

$98→$90

Buy

23.85%

Upside

Reiterated

05/07/26

Alcon price target lowered to $90 from $98 at BairdAlcon price target lowered to $90 from $98 at Baird

Matt Miksic

Barclays

$78

Hold

7.33%

Upside

Reiterated

05/06/26

Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (NASDAQ: ACAD), Qiagen (NYSE: QGEN) and Alcon (NYSE: ALC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ARWRArrowhead Pharmaceuticals

PTGXProtagonist Therapeutics

ESTAEstablishment Labs Holdings

ZVRAZevra Therapeutics

IMUXImmunic

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alcon

3 Months

Larry BiegelsenWells Fargo

Success Rate

13/19 ratings generated profit

Average Return

+2.04%

Copying Larry Biegelsen's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +2.04% per trade.

1 Year

Larry BiegelsenWells Fargo

Success Rate

12/19 ratings generated profit

Average Return

+4.05%

Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 63.16% of your transactions generating a profit, with an average return of +4.05% per trade.

2 Years

Larry BiegelsenWells Fargo

Success Rate

10/19 ratings generated profit

Average Return

+2.26%

Copying Larry Biegelsen's trades and holding each position for 2 Years would result in 52.63% of your transactions generating a profit, with an average return of +2.26% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALC Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ALC has received 10 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. ALC average Analyst price target in the past 3 months is 87.08.

Each month's total comprises the sum of three months' worth of ratings.

ALC Financial Forecast

ALC Earnings Forecast

Next quarter’s earnings estimate for ALC is $0.87 with a range of $0.82 to $0.91. The previous quarter’s EPS was $0.83. ALC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.

ALC Sales Forecast

Next quarter’s sales forecast for ALC is $2.72B with a range of $2.69B to $2.75B. The previous quarter’s sales results were $2.73B. ALC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ALC has Performed in-line its overall industry.

ALC Stock Forecast FAQ

What is ALC’s average 12-month price target, according to analysts?

Based on analyst ratings, Alcon Inc’s 12-month average price target is 87.08.

What is ALC’s upside potential, based on the analysts’ average price target?

Alcon Inc has 19.82% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ALC a Buy, Sell or Hold?

Alcon Inc has a consensus rating of Moderate Buy which is based on 7 buy ratings, 2 hold ratings and 1 sell ratings.

What is Alcon Inc’s price target?

The average price target for Alcon Inc is 87.08. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $103.32 ,the lowest forecast is $58.34. The average price target represents 19.82% Increase from the current price of $72.67.

What do analysts say about Alcon Inc?

Alcon Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of ALC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Alcon (ALC) Stock Forecast & Price Target

ALC Analyst Ratings

ALC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Alcon

ALC Analyst Recommendation Trends

ALC Financial Forecast

ALC Earnings Forecast

ALC Sales Forecast

ALC Stock Forecast FAQ

Detailed List of Analyst Forecasts